Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucosamine-6-phosphate deaminase is an enzyme (EC 3.5.99.6) that catalyzes the reversible conversion of D-glucosamine 6-phosphate and water to D-fructose 6-phosphate and ammonia, acting as a hydrolase and isomerase in the metabolism of amino sugars. Mechanistically, this enzyme opens the pyranose ring of glucosamine-6-phosphate and mediates both isomerization and deamination steps, which are essential for the hexosamine biosynthetic pathway and cellular aminosugar metabolism. It is structurally a hexameric enzyme (at least in E. coli) and is regulated allosterically—for example, by N-acetylglucosamine-6-phosphate. Although disruptions in this enzyme's function could theoretically contribute to human disease, there is little direct evidence of congenital disorders or common pathologies directly tied to glucosamine-6-phosphate deaminase deficiency in humans.
Catalyzes ring opening of glucosamine-6-phosphate, followed by base-catalyzed deamination and isomerization to fructose-6-phosphate; mechanism features Asp72 as a key proton exchanger residue
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosamine-6-phosphate deaminase.